Medicinal chitin fiber for preventing mammary gland hyperplasia, and its preparation and use
A technology of chitin fiber and mammary gland hyperplasia, which is applied in the field of medicinal fibers, can solve problems such as strong odor, and achieve the effect of simple production process, small side effects, and prevention and treatment of mammary gland hyperplasia
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] A preparation method of medicinal chitin fiber for preventing and treating breast hyperplasia:
[0024] The first step is to prepare spinning dope. First, the chitin-containing spinning dope is prepared according to the existing process, and each component is calculated by weight percentage, of which the dry solid content of chitin is 99%. Then add the drug for preventing and treating breast hyperplasia and the drug transdermal absorption enhancer into the spinning dope and stir evenly, the dry solid content of the added drug for preventing breast hyperplasia is 0.5%, and the dry solid amount of the drug added drug percutaneous absorption enhancer Is 0.5%;
[0025] The second step is to make medicinal chitin or chitosan fiber from the spinning dope containing the anti-mammary gland hyperplasia drugs and the drug transdermal absorption enhancer, and use the wet spinning process to make medicinal chitin or chitosan. Sugar fiber contains chitin or chitosan, and also contains d...
Embodiment 2
[0033] In this embodiment, the dry solid content A of chitin or chitosan in the spinning dope is 80%, the dry solid content of the drug for preventing and treating breast hyperplasia is 15%, and the dry solid content of the drug percutaneous absorption enhancer is 5%.
[0034] The method is that the spinning stock solution containing the drug for preventing and treating breast hyperplasia and the drug percutaneous absorption enhancer is made into medicinal chitin or chitosan fiber, and the fiber is spun by a dry spinning process.
Embodiment 3
[0036] In this embodiment, the dry solid content of chitin or chitosan in the spinning dope is 70%, the dry solid content of the drug for preventing and treating breast hyperplasia is 20%, and the dry solid content of the drug percutaneous absorption enhancer is 10%.
[0037] The method is as follows: the spinning stock solution containing the drug for preventing and treating breast hyperplasia and the drug percutaneous absorption enhancer is made into medicinal chitin or chitosan fiber, and a dry-jet wet spinning process is adopted.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com